In the meantime, Prostate Cancer Research's report says, screening 45-69-year-olds at high risk - black men and those with a ...

Two-thirds of men with intermediate-risk prostate cancer and nearly half of men with high-risk cancer are receiving treatment ...

At the same time, aggressive treatment declined in men with low-risk prostate cancer as might have been expected in an era ...

Radiation therapy is a standard treatment option, especially for those with localized prostate cancer. However, the side ...

In a study of US veterans, the authors say many would benefit from conservative management and active surveillance over ...

Prostate cancer is a growing problem in men, and advanced cases are rising for the first time in 20 years, which is why ...

The median follow-up duration for the entire cohort was 10.2 years, totaling 312,882 person-years of follow-up. Of these, ...

Men who undergo prostate cancer treatment face a greatly increased risk of life-altering, long-term complications, a new ...

A groundbreaking approach slows tumor growth while boosting the immune system’s defense against cancer cells. Prostate cancer ranks as the second most common cancer among men globally. Despite recent ...

November is Men’s Health Awareness Month also known as "Movember." It serves as a reminder to men to prioritize and openly ...

The risks of adverse effects and complications from treatment for prostate cancer are substantial and continue for years ...

Prostate cancer treatment guidelines recommend against aggressive therapy for those with a life expectancy of less than 10 years.